474 related articles for article (PubMed ID: 35392182)
1. The endothelial glycocalyx in critical illness: A pediatric perspective.
Richter RP; Payne GA; Ambalavanan N; Gaggar A; Richter JR
Matrix Biol Plus; 2022 Jun; 14():100106. PubMed ID: 35392182
[TBL] [Abstract][Full Text] [Related]
2. Alterations in heparan sulfate proteoglycan synthesis and sulfation and the impact on vascular endothelial function.
Pretorius D; Richter RP; Anand T; Cardenas JC; Richter JR
Matrix Biol Plus; 2022 Dec; 16():100121. PubMed ID: 36160687
[TBL] [Abstract][Full Text] [Related]
3. Endothelial glycocalyx degradation during sepsis: Causes and consequences.
Sullivan RC; Rockstrom MD; Schmidt EP; Hippensteel JA
Matrix Biol Plus; 2021 Dec; 12():100094. PubMed ID: 34917925
[TBL] [Abstract][Full Text] [Related]
4. The Endothelial Glycocalyx: Physiology and Pathology in Neonates, Infants and Children.
Puchwein-Schwepcke A; Genzel-Boroviczény O; Nussbaum C
Front Cell Dev Biol; 2021; 9():733557. PubMed ID: 34540845
[TBL] [Abstract][Full Text] [Related]
5. Increased Plasma Heparanase Activity and Endothelial Glycocalyx Degradation in Dengue Patients Is Associated With Plasma Leakage.
Buijsers B; Garishah FM; Riswari SF; van Ast RM; Pramudo SG; Tunjungputri RN; Overheul GJ; van Rij RP; van der Ven A; Alisjahbana B; Gasem MH; de Mast Q; van der Vlag J
Front Immunol; 2021; 12():759570. PubMed ID: 34987504
[TBL] [Abstract][Full Text] [Related]
6. Endothelial glycocalyx degradation in multisystem inflammatory syndrome in children related to COVID-19.
Veraldi N; Vivès RR; Blanchard-Rohner G; L'Huillier AG; Wagner N; Rohr M; Beghetti M; De Agostini A; Grazioli S
J Mol Med (Berl); 2022 May; 100(5):735-746. PubMed ID: 35347344
[TBL] [Abstract][Full Text] [Related]
7. Endothelial glycocalyx damage as a systemic inflammatory microvascular endotheliopathy in COVID-19.
Yamaoka-Tojo M
Biomed J; 2020 Oct; 43(5):399-413. PubMed ID: 33032965
[TBL] [Abstract][Full Text] [Related]
8. Heparin prevents in vitro glycocalyx shedding induced by plasma from COVID-19 patients.
Potje SR; Costa TJ; Fraga-Silva TFC; Martins RB; Benatti MN; Almado CEL; de Sá KSG; Bonato VLD; Arruda E; Louzada-Junior P; Oliveira RDR; Zamboni DS; Becari C; Auxiliadora-Martins M; Tostes RC
Life Sci; 2021 Jul; 276():119376. PubMed ID: 33781826
[TBL] [Abstract][Full Text] [Related]
9. Dengue Virus NS1 Disrupts the Endothelial Glycocalyx, Leading to Hyperpermeability.
Puerta-Guardo H; Glasner DR; Harris E
PLoS Pathog; 2016 Jul; 12(7):e1005738. PubMed ID: 27416066
[TBL] [Abstract][Full Text] [Related]
10. The endothelial glycocalyx: Structure and function in health and critical illness.
Gaudette S; Hughes D; Boller M
J Vet Emerg Crit Care (San Antonio); 2020 Mar; 30(2):117-134. PubMed ID: 32067360
[TBL] [Abstract][Full Text] [Related]
11. Endothelial Glycocalyx and Cardiopulmonary Bypass.
Myers GJ; Wegner J
J Extra Corpor Technol; 2017 Sep; 49(3):174-181. PubMed ID: 28979041
[TBL] [Abstract][Full Text] [Related]
12. Macrophage migration inhibitory factor is critical for dengue NS1-induced endothelial glycocalyx degradation and hyperpermeability.
Chen HR; Chao CH; Liu CC; Ho TS; Tsai HP; Perng GC; Lin YS; Wang JR; Yeh TM
PLoS Pathog; 2018 Apr; 14(4):e1007033. PubMed ID: 29702687
[TBL] [Abstract][Full Text] [Related]
13. Dengue virus NS1 cytokine-independent vascular leak is dependent on endothelial glycocalyx components.
Glasner DR; Ratnasiri K; Puerta-Guardo H; Espinosa DA; Beatty PR; Harris E
PLoS Pathog; 2017 Nov; 13(11):e1006673. PubMed ID: 29121099
[TBL] [Abstract][Full Text] [Related]
14. Vascular Endothelial Glycocalyx Damage and Potential Targeted Therapy in COVID-19.
Zha D; Fu M; Qian Y
Cells; 2022 Jun; 11(12):. PubMed ID: 35741101
[TBL] [Abstract][Full Text] [Related]
15. The glycocalyx core protein Glypican 1 protects vessel wall endothelial cells from stiffness-mediated dysfunction and disease.
Mahmoud M; Mayer M; Cancel LM; Bartosch AM; Mathews R; Tarbell JM
Cardiovasc Res; 2021 May; 117(6):1592-1605. PubMed ID: 32647868
[TBL] [Abstract][Full Text] [Related]
16. Prolonged Cardiopulmonary Bypass is Associated With Endothelial Glycocalyx Degradation.
Robich M; Ryzhov S; Kacer D; Palmeri M; Peterson SM; Quinn RD; Carter D; Sheppard F; Hayes T; Sawyer DB; Rappold J; Prudovsky I; Kramer RS
J Surg Res; 2020 Jul; 251():287-295. PubMed ID: 32199337
[TBL] [Abstract][Full Text] [Related]
17. Correlation between acute degradation of the endothelial glycocalyx and microcirculation dysfunction during cardiopulmonary bypass in cardiac surgery.
Wu Q; Gao W; Zhou J; He G; Ye J; Fang F; Luo J; Wang M; Xu H; Wang W
Microvasc Res; 2019 Jul; 124():37-42. PubMed ID: 30867134
[TBL] [Abstract][Full Text] [Related]
18. The glycocalyx: a novel diagnostic and therapeutic target in sepsis.
Uchimido R; Schmidt EP; Shapiro NI
Crit Care; 2019 Jan; 23(1):16. PubMed ID: 30654825
[TBL] [Abstract][Full Text] [Related]
19. Targeting Endothelial Dysfunction in Acute Critical Illness to Reduce Organ Failure.
Juffermans NP; van den Brom CE; Kleinveld DJB
Anesth Analg; 2020 Dec; 131(6):1708-1720. PubMed ID: 33186159
[TBL] [Abstract][Full Text] [Related]
20. Plasma Ameliorates Endothelial Dysfunction in Burn Injury.
Vigiola Cruz M; Carney BC; Luker JN; Monger KW; Vazquez JS; Moffatt LT; Johnson LS; Shupp JW
J Surg Res; 2019 Jan; 233():459-466. PubMed ID: 30502286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
